Oklahoma

What to verify before you order

Licensed practices new to sourcing perinatal biologics should start with their own standing, not ours. Confirm your practice's current license status with the board that governs your profession, and confirm that any medspa location has a designated medical director who documents supervision of biologic product use on site.

It is also worth checking whether a state pharmacy board or health department has published guidance on receiving, storing, and logging human cell and tissue products, since that guidance can shape your intake process. Have your own counsel review how 21 CFR 1271.10 applies to your specific intended use; whether a product qualifies as minimally manipulated and for homologous use is not something we determine for you. If you plan to order exosome products, note separately that FDA has said no exosome product is FDA-approved and that these products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, which is a further question for counsel.

• Current licensure standing with your governing medical board
• Documented medical director supervision at any medspa location
• State pharmacy board or health department guidance on HCT/P handling and storage
• Your own counsel's read on 21 CFR 1271.10 and, separately, on exosome products as biologic drugs

How accounts are verified and shipped

Every Precision Biologics account is matched against a National Provider Identifier through the NPPES registry before a first order is released. Once verified, cryopreserved orders ship overnight on dry ice in validated containers for arrival ready for -80 degree Celsius storage, while lyophilized formats ship at ambient temperature with handling instructions in the product insert.

Each tissue or exosome lot carries a unique identifier, and a certificate of analysis, donor eligibility summary, and lot release record are available on request so your practice can log the product by lot at the patient record level. We can also arrange a peer-to-peer call between your medical director and our team to walk through documentation; those calls address paperwork, not clinical decisions.

Oklahoma City and Tulsa, by the registry

Oklahoma clinic demand for the specialties we serve is concentrated in two metro areas. NPPES registry counts for providers located in Oklahoma City and Tulsa show roughly 317 orthopedic, 206 pain management, and 187 aesthetic medicine registrations combined across those two cities.

These numbers describe registered providers located in Oklahoma City and Tulsa only. They are not a statewide total, a measure of prescribing or purchasing volume, or a statement about any individual practice. Treat them as a starting point for sizing a territory, and verify current counts directly against the NPPES registry before building outreach around them.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.